Sejal Hall

Sejal Hall serves as a Member at Chief since October 2021 and as Vice President of Operations and Chief of Staff at Sonoma Biotherapeutics, Inc. since September 2020. Prior experience includes roles at Astellas Pharma as Executive Director and Head of Research Operations, where responsibilities included operational strategy for Research and Translational Science departments, and as Senior Director, Program Team Leader, focusing on early-stage gene therapy programs. Additional experience encompasses positions at Denali Therapeutics as Director of Program, Portfolio, and Alliance Management; True North Therapeutics as Director of Program Management and Team Leader; iPierian as Director of Program Management and Team Leader; and Novartis as Associate Director of Emerging Technology. Sejal Hall holds an S.B. in Chemical Engineering from the Massachusetts Institute of Technology and a Ph.D. in Chemical Engineering from UC Santa Barbara, with additional studies at Stanford University Graduate School of Business.